ReviewTherapeutic advances in medical oncology2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2- breast cancer.

Sijia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.